DR. MCCLOSKEY & PARTNERS
BANBRIDGE GROUP SURGERY, BANBRIDGE GROUP SURGERY, 1 OLD HOSPITAL ROAD, BANBRIDGE
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | None | None | NA% | |
| HF 4 | 2011 | None | None | NA% | |
| HF 4 | 2012 | None | None | NA% | |
| HF 4 | 2013 | None | None | NA% | |
| HF004 | 2014 | 0 | 0 | NA% | |
| HF004 | 2015 | 12 | 13 | 92.3% | |
| HF004 | 2016 | 19 | 22 | 86.4% | |
| HF004 | 2017 | 17 | 20 | 85.0% | |
| HF004 | 2018 | 18 | 20 | 90.0% | |
| HF004 | 2019 | 25 | 30 | 83.3% | |
| HF004 | 2020 | 43 | 45 | 95.6% | |
| HF004 | 2021 | 45 | 51 | 88.2% |
